AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $373,782,000 | +131.1% | 10,850 | +12.1% | 0.00% | – |
Q2 2020 | $161,719,000 | -58.6% | 9,678 | -64.3% | 0.00% | -100.0% |
Q1 2020 | $390,724,000 | +86.9% | 27,096 | +333.9% | 0.00% | – |
Q4 2019 | $209,020,000 | +25.5% | 6,245 | -21.5% | 0.00% | – |
Q3 2019 | $166,536,000 | +36.6% | 7,953 | +35.9% | 0.00% | – |
Q2 2019 | $121,880,000 | -45.8% | 5,854 | -41.8% | 0.00% | – |
Q1 2019 | $224,774,000 | +835.0% | 10,057 | +900.7% | 0.00% | – |
Q4 2018 | $24,040,000 | -64.4% | 1,005 | -59.3% | 0.00% | – |
Q3 2018 | $67,436,000 | +10.3% | 2,472 | +8.8% | 0.00% | – |
Q2 2018 | $61,121,000 | -74.4% | 2,273 | -69.7% | 0.00% | – |
Q1 2018 | $238,502,000 | -13.4% | 7,493 | +2.9% | 0.00% | – |
Q4 2017 | $275,292,000 | +152.5% | 7,279 | +65.5% | 0.00% | – |
Q3 2017 | $109,026,000 | +32.2% | 4,398 | +9.6% | 0.00% | – |
Q2 2017 | $82,487,000 | +741.7% | 4,012 | +789.6% | 0.00% | – |
Q1 2017 | $9,800,000 | -73.4% | 451 | -75.0% | 0.00% | – |
Q4 2016 | $36,830,000 | +13.0% | 1,801 | -17.1% | 0.00% | – |
Q3 2016 | $32,580,000 | +173.2% | 2,172 | +97.1% | 0.00% | – |
Q2 2016 | $11,924,000 | +17435.3% | 1,102 | +21940.0% | 0.00% | – |
Q1 2016 | $68,000 | -99.8% | 5 | -99.8% | 0.00% | – |
Q4 2015 | $42,102,000 | -19.5% | 2,282 | +10.5% | 0.00% | – |
Q3 2015 | $52,286,000 | – | 2,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,100,146 | $117,248,000 | 40.96% |
TLP GROUP LLC | 1,050,000 | $39,711,000 | 27.53% |
Aisling Capital LLC | 2,240,000 | $84,717,000 | 16.74% |
Foresite Capital Management III, LLC | 764,824 | $28,926,000 | 8.12% |
AlpInvest Partners B.V. | 51,498 | $1,948,000 | 6.95% |
Vivo Capital, LLC | 643,626 | $24,342,000 | 5.21% |
GREAT POINT PARTNERS LLC | 573,550 | $21,692,000 | 3.70% |
Eventide Asset Management | 1,226,000 | $46,367,000 | 2.42% |
Palo Alto Investors LP | 1,146,419 | $43,358,000 | 1.87% |
HAMILTON LANE ADVISORS LLC | 78,846 | $2,982,000 | 1.54% |